Health & Nutrition
Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8...
The deal for AtaiBeckley gives Lilly access to experimental drugs based on DMT and...
UnitedHealth blows past estimates, hikes earnings outlook...
The healthcare giant is working to stabilize margins by shrinking membership, exiting...
J&J falls despite a beat-and-raise quarter. Why we're raising...
Johnson & Johnson's quarter was imperfect, but enough is going right to validate...
The Science Behind Oatmeal and Diabetes
Before Insulin, There Was Oatmeal Before the discovery of insulin, the lives of...
A tiny GLP-1 implant is the latest bet to help patients...
Vivani Medical is developing an implant of semaglutide, the active ingredient in...
AstraZeneca's trial flop raises a bigger question: Is its...
For years, AstraZeneca has commanded one of the richest valuations among large European...
Abivax $920 million cash haul lets it prepare for solo...
Its latest fundraising round provides the French biotech with enough cash to finance...
A Surprising Vegetable Approach to Insomnia
Lactucin, the hypnotic component of lettuce, is put to the test in a randomized,...
Healthy Returns: Employers aren't expanding coverage of...
About 36% of employers said they provide coverage of GLP-1s for both diabetes and...
Healthy Returns: Employers aren't expanding coverage of...
Around 36% of employers said they provide coverage of GLP-1s for both diabetes and...